Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dina Morein"'
Publikováno v:
Cancers, Vol 14, Iss 11, p 2579 (2022)
The authors apologize for several typos/technical inaccuracies in the original article [...]
Externí odkaz:
https://doaj.org/article/86fd4e4b7ff149c589875d0dadd324ca
Publikováno v:
Cancers, Vol 14, Iss 4, p 1042 (2022)
Therapies targeting the PD-L1/PD-1 axis have recently been introduced to triple-negative breast cancer (TNBC) with limited efficacy, suggesting that this axis promotes tumor progression through mechanisms other than immune suppression. Here, we over-
Externí odkaz:
https://doaj.org/article/050f44af45f94c5794a55fa9d4a18c83
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The anti-tumor activities of some members of the chemokine family are often overcome by the functions of many chemokines that are strongly and causatively linked with increased tumor progression. Being key leukocyte attractants, chemokines promote th
Externí odkaz:
https://doaj.org/article/e96741dd7f364a8c9d5752364720ec92
Autor:
Dina Morein, Linor Rubinstein-Achiasaf, Hadar Brayer, Orly Dorot, Edward Pichinuk, Hagar Ben-Yaakov, Tsipi Meshel, Metsada Pasmanik-Chor, Adit Ben-Baruch
Publikováno v:
Cells, Vol 10, Iss 6, p 1356 (2021)
Chronic inflammation promotes cancer progression by affecting the tumor cells and their microenvironment. Here, we demonstrate that a continuous stimulation (~6 weeks) of triple-negative breast tumor cells (TNBC) by the proinflammatory cytokines tumo
Externí odkaz:
https://doaj.org/article/94384dac5686473185b1a7d1ff155cb3
Autor:
Linor Rubinstein-Achiasaf, Dina Morein, Hagar Ben-Yaakov, Yulia Liubomirski, Tsipi Meshel, Eti Elbaz, Orly Dorot, Edward Pichinuk, Michael Gershovits, Miguel Weil, Adit Ben-Baruch
Publikováno v:
Cancers, Vol 13, Iss 6, p 1472 (2021)
The pro-inflammatory cytokines tumor necrosis factor α (TNFα) and interleukin 1β (IL-1β) are expressed simultaneously and have tumor-promoting roles in breast cancer. In parallel, mesenchymal stem cells (MSCs) undergo conversion at the tumor site
Externí odkaz:
https://doaj.org/article/3425aa1900bd44108216f0b6b1e95cab
Autor:
Yulia Liubomirski, Shalom Lerrer, Tsipi Meshel, Linor Rubinstein-Achiasaf, Dina Morein, Stefan Wiemann, Cindy Körner, Adit Ben-Baruch
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The tumor microenvironment (TME) plays key roles in promoting disease progression in the aggressive triple-negative subtype of breast cancer (TNBC; Basal/Basal-like). Here, we took an integrative approach and determined the impact of tumor-stroma-inf
Externí odkaz:
https://doaj.org/article/a9f65fa008dd42b1b6a60b2fb18adc92
Autor:
Yulia Liubomirski, Shalom Lerrer, Tsipi Meshel, Dina Morein, Linor Rubinstein-Achiasaf, David Sprinzak, Stefan Wiemann, Cindy Körner, Marcelo Ehrlich, Adit Ben-Baruch
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Stromal cells and pro-inflammatory cytokines play key roles in promoting the aggressiveness of triple-negative breast cancers (TNBC; Basal/Basal-like). In our previous study we demonstrated that stimulation of TNBC and mesenchymal stem cells (MSCs) c
Externí odkaz:
https://doaj.org/article/18c8d3f7d7354e489e022ec3def690de
Autor:
Orly Dorot, Dina Morein, Linor Rubinstein-Achiasaf, Hagar Ben-Yaakov, Tsipi Meshel, Hadar Brayer, Metsada Pasmanik-Chor, Adit Ben-Baruch, Edward Pichinuk
Publikováno v:
Cells, Vol 10, Iss 1356, p 1356 (2021)
Cells
Volume 10
Issue 6
Cells
Volume 10
Issue 6
Chronic inflammation promotes cancer progression by affecting the tumor cells and their microenvironment. Here, we demonstrate that a continuous stimulation (~6 weeks) of triple-negative breast tumor cells (TNBC) by the proinflammatory cytokines tumo
Autor:
Tsipi Meshel, Dina Morein, Orly Dorot, Linor Rubinstein-Achiasaf, Eti Elbaz, Miguel Weil, Hagar Ben-Yaakov, Edward Pichinuk, Adit Ben-Baruch, Yulia Liubomirski, Michael Gershovits
Publikováno v:
Cancers
Volume 13
Issue 6
Cancers, Vol 13, Iss 1472, p 1472 (2021)
Volume 13
Issue 6
Cancers, Vol 13, Iss 1472, p 1472 (2021)
The pro-inflammatory cytokines tumor necrosis factor α (TNFα) and interleukin 1β (IL-1β) are expressed simultaneously and have tumor-promoting roles in breast cancer. In parallel, mesenchymal stem cells (MSCs) undergo conversion at the tumor site
Autor:
Cindy Körner, Yulia Liubomirski, Shalom Lerrer, Linor Rubinstein-Achiasaf, Stefan Wiemann, Tsipi Meshel, Adit Ben-Baruch, Dina Morein
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology
Frontiers in Immunology
The tumor microenvironment (TME) plays key roles in promoting disease progression in the aggressive triple-negative subtype of breast cancer (TNBC; Basal/Basal-like). Here, we took an integrative approach and determined the impact of tumor-stroma-inf